Cassava Sciences Inc vs Upstart Holdings Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Upstart Holdings Inc trades at $29.98 (market cap $2.94B). The key difference: Upstart Holdings Inc is far larger — about 61.6× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.
| FLNA | UPST | |
|---|---|---|
Market Cap | $47.75M | $2.94B |
Sector | Health | Financials |
52-Week High | $4.64 | $73.76 |
52-Week Low | $0.87 | $24.22 |
Enterprise Value | -$34.93M | — |
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →